Amarin Corp Plc (AMRN)

[KCSVEN]

Amarin website describes Anchor:
A multi-center, placebo-controlled, randomized, double-blind, 12-week pivotal Phase 3 study in patients with high triglycerides (=200 mg/dL and <500 mg/dL) who were also on statin therapy

So it is clear it was run for people on statin therapy.

Someone posted good overview of docs

https://docs.google.com/file/d/0B2TJU8mIVSebNmNxbmw0bWMwSTg/edit?usp=sharing&pli=1


I believe on the Placebo it's irrelevant, the reviewer finds the result unusual but has no idea why. Even with adjustments for the placebo Vascepa works.